Back to A1 a16z Capital Management, L.L.C.
MAZE
7 quarters
Position history for A1a16z Capital Management, L.L.C.'s holdings in Maze Therapeutics, Inc.
Yes. a16z Capital Management holds 1,702,225 shares of MAZE (Maze Therapeutics), worth $46.3M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. a16z Capital Management has listed MAZE in each of its last 7 quarterly 13F filings. MAZE is 0.2% of a16z Capital Management's reported 13F portfolio.
Current Value
$46.3M
Current Shares
1.7M
Total Value Change
+$27.5M
Total Shares Change
0
Quarter-by-Quarter History